CBFB and precursor B-cell acute lymphoblastic leukemia: CBFβ-depleted NALM-6 cells and two primary B-ALL patient samples failed to engraft and proliferate in vivo, recapitulating the dependence on RUNX1 for survival (Fig. 8b, c and Supplementary Fig. 8b–d).